- Tytuł :
- Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study.
- Autorzy :
- Źródło :
- Open Forum Infectious Diseases. Sep2020, Vol. 7 Issue 9, p1-8. 8p.
-
Czasopismo naukowe